Bernie Sanders first launched an investigation into Novo Nordisk's pricing practices for Ozempic and Wegovy in April.
From today until June 16, you can g et 40% off an annual STAT+ subscription and access all of our premium benefits. Sign up here. |
|
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2024, All Rights Reserved. | |
|
No comments